GRO-alpha (CXCL1), human recombinant (rHuGRO-a)

Item number	Size	Manual	SDS	Delivery time	Price
94867.5	5 µg	-	-	3 - 10 business days*	94.00€
94867.25	25 µg	-	-	3 - 10 business days*	208.00€
94867.1	1 mg	-	-	3 - 10 business days*	3,952.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Has chemotactic activity for neutrophils. May play a role in inflammation and exerts its effects... more

Close menu

Product information "GRO-alpha (CXCL1), human recombinant (rHuGRO-a)"

Has chemotactic activity for neutrophils. May play a role in inflammation and exerts its effects on endothelial cells in an autocrine fashion. In vitro, the processed forms GRO-alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) show a 30-fold higher chemotactic activity. (www.uniprot.org) Produced in E.coli as a single, non-glycosylated, polypeptide chain containing 73 amino acids. CXCL1 plays a role in spinal cord development and is involved in the processes of angiogenesis, inflammation, wound healing, and tumorigenesis.

Keywords:	Growth-regulated protein alpha, CXCL1, Melanoma growth stimulatory activity, MGSA, Neutrophil-activating protein 3, NAP-3, GRO-alpha (1-73), chemokine (C-X-C motif) ligand 1, GRO1, GROa, SCYB1, MGSA-a, MGSA alpha
Supplier:	Biomol GmbH
Supplier-Nr:	94867